Robert Guthrie Symposium 2022

Picture of Dr. Robert Guthrie.

Dr. Robert Guthrie, known as the "Father of Newborn Screening," checks on one of the infants who benefited from his work in this 1982 photo. Courtesy UB Archives.

The 2022 Robert Guthrie Symposium is an all-day, hybrid educational event honoring the life and legacy of Robert Guthrie, MD, PhD, and his attachment to the University at Buffalo and Oishei Children's Hospital.

This year, our focus is on the past, present, and future of newborn screening and metabolic disorders.  The goal of the event is to educate professionals and patients on metabolic disorders and their treatment options, as well as the history and current practices of newborn screening.

This annual symposium is a forum for world-renowned physicians and scientists to share their knowledge with providers, families and community stakeholders. Our speakers will discuss pioneering research and clinical practices in genetic and metabolic disorders.

Symposium Details

The Annual Guthrie Symposium was held on June 28, 2022 at M&T Auditorium, Jacobs School of Medicine and Biomedical Sciences.

You can view the materials from the event below!

View the Recorded Video
View the Photos
  • Robert Guthrie, MD, PhD
    4/11/22
    Robert Guthrie was born on June 28, 1916, in Marionville, Missouri. His education as a physician and a scientist was circuitous but extensive, resulting in his earning six degrees across two institutions, including his MD in bacteriology in 1945 and his PhD in biochemistry in 1946 from the University of Minnesota.
Robert Guthrie.

Photo: UB ARCHIVES

Agenda

8:00 am – 9:00 am

Registration

Opening Session Host: Taosheng Huang, MD, PhD

9:00 am – 9:30 am

Opening Remarks

Allison Brashear, MD, MBA
 Vice President for Health Sciences and
Dean, Jacobs School of Medicine and Biomedical Sciences

Steven E. Lipshultz, MD
A. Conger Goodyear Professor and Chair of the Department of Pediatrics
Pediatric Chief-of-Service, Kaleida Health
Medical Director of Pediatric Services Business Development, Oishei Children's Hospital
President, UBMD Pediatrics

Stephen J. Turkovich, MD
Chief Medical Officer, Oishei Children’s Hospital
Clinical Assistant Professor, Department of Pediatrics

9:30 am – 9:50 am

Diagnostic Odyssey of Dr. Robert Guthrie’s Granddaughter

James Guthrie, PhD
 Dr. Robert Guthrie’s son, Professor Emeritus, the University of Kansas School of Business 

9:50 am – 10:20 am

Keynote

Current Status of Newborn Screening: a View from Europe and Developing Countries

James Bonham, PhD
 President, International Society of Neonatal Screening
Co-Chair, Global Task Force on Newborn Screening

10:20 am – 10:50 am

Making Decisions About Expanding Newborn Screening

Alex Kemper, MD, MPH, MS
 Division Chief, Primary Care Pediatrics, Nationwide Children’s Hospital
Professor of Pediatrics, The Ohio State University College of Medicine
Chair, Condition Review Workgroup, U.S. Secretary of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children

10:50 am - 11:00 am

Break

Midday Session Host: Steven Lipshultz, MD

11:00 am - 11:30 am

Robert Guthrie Lifetime Achievement Award Ceremony Presented by the Guthrie Family, Drs. Lipshultz and Huang, and Other Committee Members

Harvey Levy, MD
 Senior Physician in Medicine and Genetics, Division of Genetics and Genomics, Boston Children's Hospital
Professor of Pediatrics, Harvard Medical School

R. Rodney Howell, MD
 Emeritus Professor and Chair, Department of Pediatrics
Emeritus member, Hussman Institute for Human Genomics,
University of Miami Miller School of Medicine

11:30 am – 12:00 pm

Striving for Excellence: Improving Sensitivity and Specificity by Altering Newborn Screening Test Algorithms

Michele Caggana, ScD, FACMG
 Deputy Director, Division of Genetics
Chief, Laboratory of Human Genetics
Director, Newborn Screening Program, New York State Department of Health's Wadsworth Center

12:00pm – 12:30pm

Keynote

Optimizing Newborn Screening to Maximize Specificity and Sensitivity

Tricia Hall, PhD
 Co-Director, Biochemical Genetics Laboratory at Mayo Clinic

12:30pm – 1:20pm

Lunch & PKU Formula Testing

Staci Kasprzyk
 Board Member, Mid-Atlantic Connection for PKU and Allied Disorders

1:20 pm- 1:30 pm

Grand Reopening of the Robert Guthrie Laboratory

Afternoon Session Host: Margaret McGlynn, RPh

1:30 pm – 2:00 pm

Keynote

Recent Advancements in Developing New Treatments and Therapies for Metabolic Diseases

Gerard Berry, MD
 President, Society for Inherited Metabolic Disorders
Director, Metabolism Program and Harvey Levy Chair in Metabolism, Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School

2:00 pm – 2:30 pm

A Genetic Medicine Approach toward the Cure of PKU

Albert Seymour, PhD
 Chief Scientific Officer, Homology Medicines, Inc.

2:30 pm – 3:00 pm

The Congenital Disorders of Glycosylation Potentially Included in Newborn Screening

Miao He, PhD
 Co-Director, KSL/Robert Guthrie Laboratory
Co-Director, Michael Palmieri Laboratory for Metabolic and Advanced Diagnostics, Children’s Hospital of Philadelphia
Adjunct Associate Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine

3:00 pm – 3:30 pm

Enhancement of the Newborn Screening Paradigms for Krabbe disease, Mucopolysaccharidosis Type 1 and Pompe disease by Application of Bivariate Normal Limit Theory

Thomas J. Langan, MD
 Clinical Research Director, Institute for Myelin and Glia Exploration (IMAGE)
Associate Professor of Neurology, Pediatrics, and Physiology and Biophysics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences

Panel Session Host: Teresa Campbell, MS, CGC

3:30 pm - 4:00 pm

Panelists

  • James Guthrie, PhD
  • Patricia Guthrie, MA
  • Gerard Berry, MD
  • Alex Kemper, MD
  • Michele Caggana, ScD, FACMG
  • Tricia Hall, PhD
  • James Bonham, PhD
  • Miao He, PhD
  • Albert Seymour, PhD
  • Thomas Langan, MD
  • Staci Kasprzyk
  • Margie McGlynn, RPh
  • Taosheng Huang, MD, PhD

4:00 pm – 4:10 pm

Closing Remarks

Taosheng Huang, MD, PhD
 Chair, Guthrie Symposium Planning Committee,
Professor and Division Chief, Genetics, Department of Pediatrics, University at Buffalo
Director of Medical Genetics, Oishei Children’s Hospital

Speakers

  • Allison Brashear, MD, MBA
    5/25/22
    Dr. Allison Brashear is the UB Vice President for Health Sciences and Dean of Jacobs School of Medicine and Biomedical Sciences (JSMBS). Internationally recognized as a prolific scientist, neurologist, and health science administrator, Dr. Brashear is responsible for providing overall leadership to the JSMBS while also promoting academic excellence, fostering an inclusive environment, and advancing the school’s national and international prominence in basic and translational research, medical education, clinical engagement, and service. Previously, Dr. Brashear served as the Dean of the University of California, Davis, School of Medicine from 2019 until 2021. Under her leadership, the UC Davis achieved record research awards of $368 million and more than doubled its clinical trial awards in 2021. During her time in California, she also held a position on the California Institute for Regenerative Medicine (CIRM) board of directors. Prior to joining UC Davis, Dr. Brashear served as the Chair of Neurology at Wake Forest School of Medicine, where she held the Walter C. Teagle Endowed Chair of Neurology and was one of the first faculty members appointed to the Wake Forest Baptist Medical Center board of directors.
  • Steven E. Lipshultz, MD
    5/25/22
    Dr. Steven E. Lipshultz is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, The State University of New York; the Chief of Service of Pediatrics at Kaleida Health; the Medical Director of Pediatric Services Business Development at John R. Oishei Children’s Hospital; President of UBMD Pediatrics; and a Consultant in Pediatrics and Cardio-Oncology for the Roswell Park Comprehensive Cancer Center. Dr. Lipshultz came to UB in 2018 from Wayne State University, where he held the Carman and Ann Adams Endowed Chair of Pediatric Research at Wayne State University School of Medicine and Children’s Hospital of Michigan. Prior to that, he held the George E. Batchelor Endowed Chair in Pediatric Cardiology at the University of Miami Leonard M. Miller School of Medicine. He also served as chief of staff of Holtz Children’s Hospital at the University of Miami/Jackson Memorial Medical Center, one of the largest children’s hospitals in the Southeast.
  • Stephen J. Turkovich, MD
    5/25/22
    Dr. Stephen J. Turkovich is the Vice President and Chief Medical Officer, Maternal & Child Health, Oishei Children’s Hospital and Clinical Assistant Professor, Department of Pediatrics, Jacobs School of Medicine & Biomedical Sciences. As a long-time resident of Buffalo, Dr. Turkovich received his Bachelor of Arts in anthropology as well as his medical degree from the University at Buffalo (UB). He completed his pediatric residency at the University of Rochester, Golisano Children's Hospital, and worked clinically as a pediatric hospitalist including newborn nursery medicine since 2006 at Women & Children's of Hospital of Buffalo (WCHOB). In 2008, he assumed the role of Quality & Patient Safety Officer for WCHOB with a focus on decreasing hospital acquired infections, improving patient experience, decreasing readmissions, improving sepsis outcomes, and improving breastfeeding rates. In 2014, he was named the Vice President and Chief Medical Officer of WCHOB and was part of the team that led the move to the new Oishei Children's Hospital in 2017.
  • Patricia Guthrie, MA
    5/17/22
    Patricia Guthrie is Dr. Robert Guthrie's daughter and one of the special guest speakers at this year's Symposium. As a newspaper reporter, she focused on public health, chronic diseases, and social issues surrounding healthcare. She received numerous national awards, including the George Polk Award for Local Reporting for a series she co-wrote for The Albuquerque Tribune in 1988 on chronic alcoholism in Gallup, N.M. In 1999, she was named a Kiplinger Fellow at The Ohio State University, where she earned a master's degree in journalism. Four years later, she was selected for the prestigious Harvard Nieman Fellowship for Journalism. One of her primary pursuits in recent years is memorialiing and celebrating her father's contributions to newborn screening and the treatment of metabolic disorders. She’s spoken at numerous meetings— National Alliance for PKU, Paul M. Fernhoff Memorial Lecture, Association for Public Health Laboratories, Dr. Harvey Levy Program Inaugural Symposium, European Society for PKU and Allied Disorders, the Senate of the Republic of Mexico, and contributed articles to several international PKU publications. In 2014 she wrote and narrated a video for the March of Dimes to celebrate their newly created “Dr. Robert Guthrie Newborn Screening Quality Award” (Robert Guthrie Award - YouTube), shown at annual conferences. In 2016 — on the 100th anniversary of her father’s birth — she founded “The Robert Guthrie Legacy Project” (www.robertguthriepku.org) to help document and promote Dr. Guthrie's legacy to the broader community. Patricia Guthrie is Dr. Robert Guthrie's daughter and one of the special guest speakers at this year's Symposium. She is an independent journalist from Seattle, Washington, specializing in writing about public health, chronic diseases, and social issues surrounding healthcare. Her writing has frequently appeared in the Huffington Post, Bloomberg News, the Canadian Medical Association Journal, and the Nursing Association Journal. She has received multiple awards for her work on these subjects, including the Don Bolles Award and the Scripps-Howard Award. In 1988, she received the George Polk Award for Local Reporting for a series she co-wrote for the Albuquerque Tribune on chronic alcoholism in Gallup, NM. She was also a Kiplinger Fellow at The Ohio State University, where she earned a master's degree in journalism. She has made it one of her primary goals to memorialize and celebrate her father's contributions to newborn screening and treating metabolic disorders. As part of these efforts, she has founded the The Robert Guthrie Legacy Project in 2016 to help document and promote Dr. Guthrie's legacy to the broader community.
  • Harvey Levy, MD
    5/17/22
    Dr. Harvey Levy is Senior Physician in Medicine and Genetics, Division of Genetics and Genomics at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School. Over his long and storied career, he has made multiple seminal contributions to the diagnosis, treatment, and scientific understanding of metabolic disorders. Following his graduation from the Medical College of Georgia in 1960, Dr. Levy trained in pediatrics at Boston City Hospital, Columbia-Presbyterian Medical Center, and Johns Hopkins Hospital. After his pediatrics training, he briefly rejoined the Boston City Hospital as chief resident of pediatrics before taking a position at Massachusetts General Hospital (MGH) as a research fellow in metabolism and pediatric neurology research under Dr. Mary Efron, a pioneer in metabolism and metabolic disease. After completing this fellowship, Dr. Levy joined the faculty of the MGH and Harvard and also served as a consultant in metabolism to the Massachusetts newborn screening program. In 1978, Dr. Levy moved to Boston Children’s Hospital to found and serve as the first director of the metabolic program.
  • Margaret McGlynn, RPh
    5/17/22
    Margaret (Margie) McGlynn is an alumna of the University at Buffalo and a major donor to the Margaret Hempling McGlynn Endowed Chair in Clinical Pharmacy in the UB School of Pharmacy and Pharmaceutical Sciences. She received her BS in pharmacy, MBA in marketing and Honorary Doctorate in Sciences from the University at Buffalo. During her career in the private sector, Margie spent 26 years at Merck, where she served in leadership roles in marketing, new product development, and managed care. Her final position at Merck was as President, Global Vaccines and Anti-Infectives. After retiring from Merck, Margie served for 4 years as president and chief executive officer of the International AIDS Vaccine Initiative (IAVI), a product development partnership that helps accelerate HIV vaccine development by bridging government and philanthropic funding with academic and industry vaccine research and development capabilities. Margie also serves on the boards of Vertex Pharmaceuticals, Amicus Therapeutics, Novavax, Inc. and Life Science Cares, Philadelphia.
  • Michele Caggana, ScD, FACMG
    5/17/22
    Dr. Michele Caggana is Chief of the Laboratory of Human Genetics and Director of the Newborn Screening Program at the New York State Department of Health's Wadsworth Center. She also serves as the Deputy Director for the Division of Genetics and co-lead of the Genetic Testing Section for the Clinical Laboratory Evaluation Program. Dr. Michele Caggana joined the Wadsworth Center in 1996, after receiving her doctoral degree from the Harvard School of Public Health and completing her post-doctoral work in molecular virology (also at the Wadsworth Center) and clinical molecular genetics at the Mt. Sinai School of Medicine. 
  • R. Rodney Howell, MD
    5/17/22
    Dr. R. Rodney Howell is a Professor and Chairman of Pediatrics Emeritus at the Miller School of Medicine at the University of Miami. He is an elected fellow of the American Association for the Advancement of Science. The author of more than 150 original articles and abstracts on genetic disorders in children, Dr. Howell’s pioneering work has benefited countless infants and children worldwide. Dr. Howell's skill in advancing the genetic and genomic medicine agenda has been pivotal in improving global public health.
  • Taosheng Huang, MD, Ph.D
    5/25/22
    Dr. Taosheng Huang is the Chief of Genetics for Pediatrics at SUNY Buffalo, Director of Genetics & Metabolism at Oishei Children’s Hospital, and Program Director of Clinical Cancer Genetics at Great Lakes Cancer Center. He is a physician-scientist who is board-certified in Pediatrics, Clinical Genetics and Clinical Molecular Genetics with over 25 years of experience in translation research, metabolic disease, and mitochondrial medicine. Prior to joining UB, he served for eight years as Professor in Human Genetics, as well as the founding Director of the Program of Mitochondrial Medicine and Director of the Molecular Diagnostic laboratory at Cincinnati Children‘s Hospital Medical Center.  Before moving to CCHMC, he was also Associate Professor of Pediatrics, Developmental and Cell Biology, and Pathology at the University of California, Irvine, where he was the Director for the MitoMed Molecular Diagnostic Laboratory and Director of the Cardiovascular Genetics Clinic.
  • Albert Seymour, Ph.D
    6/23/22
    Dr. Albert Seymour is the Chief Scientific Officer at Homology Medicines, Inc.  He received his Bachelor’s degree in Biology from the University of Delaware, followed by his Master’s in Molecular Genetics from The Johns Hopkins University School of Medicine.  In 1997, Dr. Seymour completed his PhD in Human Genetics at the University of Pittsburgh.  He has since spent more than 20 years combining his talents in pharmaceutical R&D with human genetics, resulting in the delivery of several therapeutic programs into development.  Before joining Homology, Dr. Seymour was the Senior Vice President and Global Head of Research and Nonclinical Development at Shire.  Prior to this role, he also served as the VP and Head of Drug Discovery and Translational Research at Shire, where he doubled the rare disease discovery portfolio in three years.  Dr. Seymour is also a member of the Board of Directors of Ensoma.
  • James Guthrie, Ph.D
    6/21/22
    Dr. James Guthrie is Dr. Robert Guthrie’s son and a special guest speaker this year.  He is Professor Emeritus at the University of Kansas School of Business.  He received his B.A. in Psychology from the State University of New York at Buffalo in 1979, his MBA from SUNY-Buffalo in 1983 and his Ph.D. in Management from the University of Maryland, College Park in 1989.  During his nearly 40 years of teaching he taught scores of undergraduate, masters, doctoral students and working professionals.  His teaching reflected his research interests:  How best to manage people to improve both the employee experience and firm success.  He has published widely, is highly cited and his work has been discussed in a variety of media outlets (e.g., NY Times, Washington Post, Wall Street Journal, Harvard Business Review, etc.). Dr. Guthrie’s personal odyssey involving his daughter’s rare genetic condition connected him with his father’s research on an individual level.
  • James Bonham, Ph.D
    6/21/22
    Dr. James R. Bonham is the president of the International Society of Neonatal Screening (ISNS), which includes over 500 members in 80 countries.  He served as a Clinical Director at the Sheffield Children’s Hospital from 1992 until 2018, and a trustee for the Children’s Hospital Charity until 2013.  He began working for Public Health England (PHE) in 2015, where he serves as the UK National Laboratory Lead for the Newborn Screening Blood Spot Programme.  In his role as President of the ISNS, Dr. Bonham has helped impact the lives of thousands of babies and has helped to extend newborn screening programs into low and middle income countries.  In 2019, Dr. Bonham was awarded an MBE for the national impact of his services on young people with genetic metabolic diseases. 
  • Alex Kemper, MD, MPH, MS
    6/21/22
    Dr. Alex Kemper is the Division Chief of Primary Care Pediatrics at Nationwide Children’s Hospital and Professor of Pediatrics at the Ohio State University College of Medicine and Deputy Editor of Pediatrics.  Dr. Kemper attended medical school and completed his pediatric residency training at Duke University followed by combined fellowship training in health services research and medical informatics with residency training in preventive medicine at the University of North Carolina.  His research focuses on the delivery of preventive services in the primary care practice setting.  Dr. Kemper is a former member of the U.S. Preventive Services Task Force and is the Chair of the Evidence Review Group for the U.S. Secretary of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children.  Dr. Kemper has authored more than 250 peer-reviewed journal articles, book chapters, and commentaries.  Dr. Kemper was honored with the 2015 R. Rodney Howell Award for Excellence in Newborn Health from the Newborn Foundation.
  • Tricia Hall, Ph.D
    6/23/22
    Dr. Patricia (Tricia) Hall is a Co-Director of the Biochemical Genetics Laboratory at Mayo Clinic, Rochester MN.  She received both her Bachelor’s and PhD degrees in Chemistry from the University of Regina.  Dr. Hall served as a postdoctoral fellow at the University of Saskatchewan until 2011, followed by an ABMG Biochemical Genetics Fellow at Mayo Clinic until 2013.  She served as a Co-Chair on the Newborn Screening Advisory Committee at the Georgia Department of Public Health for more than 5 years, and she is certified in Clinical Biochemical Genetics by the American Board of Medical Genetics and Genomics.  In 2015, Dr. Hall received the Richard King Trainee Award by the American College of Medical Genetics and Genomics (ACMG) for her manuscript titled, “Postanalytical tools to improve performance of newborn screening by tandem mass spectrometry”.  Recently, she served as Newborn Screening Laboratory Director at the Georgia Department of Public Health.  Her research interests include newborn screening performance improvement, with a particular focus on the reduction of false positive screens, allowing accurate diagnosis and prompt treatment for those infants who require it, and minimizing the disruption and stress for those who do not.
  • Staci Kasprzyk
    6/23/22
    Staci Kasprzyk is on the board of the Mid-Atlantic Connection for PKU and Allied Disorders.  In 2014, Ms. Kasprzyk’s first child, Norah, was born.  Soon after her birth, Norah was diagnosed with PKU, and Ms. Kasprzyk explains how she found support during this critical time from parents in the area, as well as support groups.  Now, Ms. Kasprzyk is an advocate for patients with PKU, and she is involved with many groups and events contributing to finding a cure.  She served as the chairperson for the 2017 “Lifting the Limits for PKU” gala, and went to Washington, D.C. to lobby for the Medical Foods Equity Act with the National PKU Alliance.
  • Miao He, Ph.D
    6/23/22
    Dr. Miao He is Co-Director at the Michael Palmieri Laboratory for Metabolic and Advanced Diagnostics at Children’s Hospital of Philadelphia. She received her Ph.D. in Genetics from the University of Leeds in 1999.  After Dr. He completed her postgraduate training and fellowship appointments at Mayo Medical School and University of Pittsburgh, she had served as the Director of Emory Biochemical Genetics Laboratory during 2008-2013 and assistant professor of human genetics at Emory University School of Medicine. She currently also works as an adjunct Associate Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine.  Dr. He serves on the American Association of Clinical Chemistry, the American Society of Human Genetics, the Society for Inherited Metabolic Disorders, and the American College of Human Genetics.  She works as a peer reviewer for a multitude of academic journals, including the Journal of Inherited Metabolic Disease and has received various awards throughout her career.
  • Thomas J. Langan, MD
    6/21/22
    Dr. Thomas J. Langan is the Director for Clinical Research of the Institute For Myelin and Glia Exploration, as well as an Associate Professor of Neurology, Pediatrics, and Physiology and Biophysics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences.  He received both his undergraduate degree in Biology and his MD in Medicine from Brown University.  Dr. Langan completed his residency in Pediatrics in 1981, and his residency in Neurology in 1984, both at Washington University.  He has been involved in several leadership roles in organizations throughout Western New York and New York State, helping to facilitate significant recruitment into multi-center research studies.  These organizations include the New York State Krabbe Disease Consortium, where Dr. Langan serves as President, as well as the Headache and Concussion clinics at Children’s Hospital of Buffalo, where he served as Director.  Dr. Langan has received numerous awards and honors throughout his career, including election to Best Doctors in America in 1999, and selection as the Castle Connolly Best Doctor from 2000 to 2015.
  • Gerard Berry, MD
    5/25/22
    Dr. Gerard Berry is the President of the Society for Inherited Metabolic Disorders (SIMD).  He attended Jefferson Medical College in Philadelphia, where he graduated in 1975.  He then trained in Thomas Jefferson University Hospital and Children’s Hospital of Philadelphia.  In 1981, Dr. Berry became an Assistant Professor of Pediatrics at the University of Pennsylvania School of Medicine, where he was promoted to Professor of Pediatrics in 1995.  He currently serves as the Director of the Metabolism Program and the Harvey Levy Chair in Metabolism at Boston Children’s Hospital, as well as the Director of the Harvard Medical School Biochemical Genetics Training Program.  Dr. Berry is also the co-chair of the Undiagnosed Diseases Network (UDN) metabolomics working group.  Throughout his career, he has contributed to more than 200 publications, and in 2004, Dr. Berry received the Emmanuel Shapiro SIMD Award.

Planning Committee

  • Taosheng Huang (Chair of the Planning Committee): UBMD Pediatrics, University at Buffalo
  • Staci Kasprzyk: National PKU Alliance
  • Amy Lachuk: The Children's Hospital of Buffalo Foundation
  • Andy Lashua: The Children's Hospital of Buffalo Foundation
  • Margie McGlynn: HCU Network America
  • Kathy Rygg: UBMD Pediatrics
  • Jesse Slone: UBMD Pediatrics
  • Kathy Swenson: Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
  • Jennifer Britton: Division of University Advancement, University at Buffalo
  • Abigail Robertson: The Children's Hospital of Buffalo Foundation
  • Miura Wiley: Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
  • Renee Zureck: KSL Diagnostics

Sponsors

Jacobs School of Medicine and Biomedical Sciences.

To make a donation to the UB Foundation, please click here.

UBMD Peds.
CHF.

To make a donation to The Children's Hospital of Buffalo Foundation, please click here.

Sponsorship support from

Genome Sponors

Horizon Logo.
Biomarin.
Takeda Logo.
Sanofi.

Double Helix Sponsors

Nutricia Logo.
Baylor Genetics.
WNY PKU Association.
Vitaflo, Enhancing Lives Together, A Nestlé Science Company.

Exome Sponors

KSL Diagnostics Logo.

Gene Panel Sponsors

Hempling Foundation for Homocystinuria Research Logo.
Ajinomoto Cambrooke.